Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-20

FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)

View source ↗

Summary

FDA approved a supplemental application for Belbuca (buprenorphine hydrochloride buccal film) to support its labeling for the treatment of chronic pain in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BELBUCA (Buprenorphine hydrochloride)

Snippet

SUPPL AP for BELBUCA (BUPRENORPHINE HYDROCHLORIDE)